CBLL
CeriBell, Inc.
NasdaqGSUSDEQUITY
Healthcare
DELAYED
Last price
24.20
▼ 0.11 (0.45%)
MARKET · —
Price
Too many bars for candle bodies at this width — showing high/low range per bar. Zoom in or pick a shorter range.
Open
24.31
Prev close
24.31
Day high
24.31
Day low
23.80
Volume
290.10K
Market cap
$928.75M
P/E (TTM)
—
52W range
10.85 – 25.33
Insider net activity
Net shares
+36.55K
Net buying
Buy transactions
25
567.48K shares
Sell transactions
26
530.92K shares
Net transactions
+51
Buys less sells
Sell : buy shares
0.9 : 1
Mixed
Insider-held shares
4.58M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 13, 26 | TAYLOR JOSEPH MICHAEL Director |
SELL | 13.10K | $306.42K | Direct |
| Aug 13, 26 | CHAO XINGJUAN Chief Executive Officer |
CONVERSION | 33.10K | $109.39K | Direct |
| Aug 3, 26 | CHAO XINGJUAN Chief Executive Officer |
SELL | 39.00K | $714.48K | Direct |
| Aug 3, 26 | CHAO XINGJUAN Chief Executive Officer |
CONVERSION | 25.00K | $117.50K | Direct |
| Jul 28, 26 | O'KEEFE SHARON L Director |
STOCK | 16.01K | $0 | Direct |
| Jul 28, 26 | WEST THOMAS A Director |
STOCK | 16.01K | $0 | Direct |
| Jul 7, 26 | CHAO XINGJUAN Chief Executive Officer |
SELL | 39.00K | $776.10K | Direct |
| Jul 7, 26 | CHAO XINGJUAN Chief Executive Officer |
CONVERSION | 25.00K | $117.50K | Direct |
| Jun 30, 26 | BURKE WILLIAM W Director |
SELL | 2.21K | $43.79K | Direct |
| Jun 26, 26 | TPG GP A, L.L.C. Unknown |
SELL | 202.37K | $4.07M | Indirect |
| Jun 11, 26 | TAYLOR JOSEPH MICHAEL Director |
SELL | 5.50K | $101.25K | Direct |
| Jun 8, 26 | CHAO XINGJUAN Chief Executive Officer |
SELL | 39.00K | $714.87K | Direct |
| Jun 8, 26 | CHAO XINGJUAN Chief Executive Officer |
CONVERSION | 25.00K | $117.50K | Direct |
| Jun 2, 26 | TAYLOR JOSEPH MICHAEL Director |
STOCK | 7.84K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BLUMBERG SCOTT |
Chief Financial Officer | 147.68K | Sale |
CHAO XINGJUAN |
Chief Executive Officer | 1.19M | Conversion of Exercise of derivative security |
FOEHR DAVID |
Officer | 37.75K | Sale |
MANNI JOSEPH S |
Officer | 56.29K | Sale |
PARVIZI JOSEF |
Director | 2.01M | Stock Award(Grant) |
ROGERS ERICA J. |
Director | 33.05K | Stock Award(Grant) |
TAMMENOMS BAKKER JULIET |
Director | 2.50M | Stock Award(Grant) |
TAYLOR JOSEPH MICHAEL |
Director | 48.48K | Sale |
TPG GP A, L.L.C. |
Unknown | — | Sale |
WOO RAYMOND |
Chief Technology Officer | 195.68K | Sale |
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Options analytics
Put / call volume
0.67
Call-heavy session
Put / call open interest
3.07
Positioning, not flow
Max pain
7.50
-69.0% from spot
ATM implied vol
61.5%
Nearest strike to spot
Skew (10% OTM)
+217.4%
Puts bid over calls
Call volume
6
Contracts, this expiry
Put volume
4
Contracts, this expiry
Heaviest call OI
7.50
26 contracts
Heaviest put OI
7.50
120 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Trailing performance
Returnvs SPY
1W
+3.73%
+5.1%
1M
+48.65%
+44.9%
3M
+29.14%
+26.0%
6M
+19.68%
+8.6%
YTD
+10.35%
-1.9%
1Y
+108.98%
+89.0%
3Y
—
-74.2%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap$928.75M
Enterprise value$821.40M
Revenue (TTM)$101.96M
Gross profit$90.64M
EBITDA$-68.80M
Net income$-66.00M
EPS (TTM)$-1.76
Free cash flow$-33.05M
Total cash$129.26M
Total debt$21.91M
Book value / share$3.36
Shares outstanding38.38M
Float26.49M
Short % of float8.11%
Dividend yield—
Beta (5Y)—
Short interest
Shares short
2.02M
Prior 1.98M
Change vs prior
+2.2%
Shorts adding
% of float
8.11%
Normal
% of shares out
5.28%
Against total outstanding
Days to cover
5.5
Crowded exit
Float
26.49M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Valuation & profitability ratios
Trailing P/E—
Forward P/E-15.74
PEG ratio—
Price / sales—
Price / book7.21
EV / revenue8.06
EV / EBITDA-11.94
Gross margin88.90%
Operating margin-71.11%
Profit margin-64.73%
Return on equity-43.93%
Return on assets-23.38%
Debt / equity17.08
Current ratio9.18
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $89.06M | $65.44M | $45.23M | $25.92M | +36.1% |
| Operating revenue | $89.06M | $65.44M | $45.23M | $25.92M | +36.1% |
| Cost of revenue | $10.79M | $8.69M | $7.06M | $4.43M | +24.1% |
| Gross profit | $78.27M | $56.75M | $38.16M | $21.49M | +37.9% |
| Research & development | $19.14M | $13.56M | $8.99M | $7.24M | +41.2% |
| Selling, general & admin | $117.53M | $82.90M | $59.21M | $50.27M | +41.8% |
| Total operating expense | $136.68M | $96.46M | $68.20M | $57.51M | +41.7% |
| Operating income | -$58.40M | -$39.71M | -$30.04M | -$36.02M | -47.1% |
| Net interest income | -$1.89M | -$1.99M | -$2.10M | -$1.60M | +5.1% |
| Pre-tax income | -$53.41M | -$40.45M | -$29.45M | -$37.16M | -32.0% |
| Tax provision | $0 | $0 | $11.00K | $2.00K | — |
| Net income | -$53.41M | -$40.45M | -$29.46M | -$37.16M | -32.0% |
| Net income to common | -$53.41M | -$40.45M | -$29.46M | -$37.16M | -32.0% |
| Basic EPS | -1.46 | -3.39 | -1.26 | -1.59 | +56.9% |
| Diluted EPS | -1.46 | -3.39 | -1.26 | -1.59 | +56.9% |
| EBIT | -$51.52M | -$38.46M | -$27.36M | -$35.56M | -34.0% |
| EBITDA | -$50.18M | -$37.32M | -$26.51M | -$35.06M | -34.5% |
| Basic shares | 36.54M | 11.95M | 23.32M | 23.32M | +205.8% |
| Diluted shares | 36.54M | 11.95M | 23.32M | 23.32M | +205.8% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $40.48M | $194.37M | $34.49M | $68.23M | -79.2% |
| Cash & short-term investments | $159.26M | $194.37M | $34.49M | $68.23M | -18.1% |
| Accounts receivable | $15.05M | $10.88M | $7.96M | $5.29M | +38.4% |
| Inventory | $7.29M | $6.94M | $5.87M | $4.08M | +5.1% |
| Total current assets | $186.72M | $217.27M | $51.96M | $79.80M | -14.1% |
| Property, plant & equipment | $4.33M | $4.45M | $3.74M | $3.87M | -2.7% |
| Total assets | $195.80M | $225.41M | $58.92M | $86.46M | -13.1% |
| Total current liabilities | $19.19M | $12.99M | $21.60M | $9.86M | +47.7% |
| Current debt | — | — | $11.83M | $2.50M | — |
| Long-term debt | $19.81M | $19.56M | — | $12.72M | +1.3% |
| Total debt | $22.28M | $21.96M | $14.20M | $18.22M | +1.4% |
| Total liabilities | $40.47M | $34.25M | $171.17M | $172.86M | +18.2% |
| Retained earnings | -$220.36M | -$166.94M | -$126.49M | -$97.03M | -32.0% |
| Shareholder equity | $155.34M | $191.16M | -$112.25M | -$86.40M | -18.7% |
| Working capital | $167.53M | $204.28M | $30.36M | $69.94M | -18.0% |
| Net tangible assets | $155.34M | $191.16M | -$112.25M | -$86.40M | -18.7% |
| Shares issued | 37.49M | 35.85M | 34.02M | 34.02M | +4.6% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$53.41M | -$40.45M | -$29.46M | -$37.16M | -32.0% |
| Depreciation & amortisation | $1.34M | $1.14M | $847.00K | $497.00K | +17.5% |
| Stock-based compensation | $12.22M | $5.41M | $2.68M | $7.93M | +125.9% |
| Change in working capital | $633.00K | -$3.17M | -$3.70M | -$3.88M | +120.0% |
| Operating cash flow | -$40.81M | -$35.04M | -$29.16M | -$32.00M | -16.5% |
| Capital expenditure | -$767.00K | -$1.34M | -$983.00K | -$516.00K | +42.8% |
| Investing cash flow | -$118.14M | -$1.60M | -$1.76M | -$1.40M | -7,292.8% |
| Share buybacks | — | — | $0 | -$310.00K | — |
| Financing cash flow | $5.05M | $196.52M | -$2.82M | $49.80M | -97.4% |
| Free cash flow | -$41.58M | -$36.38M | -$30.14M | -$32.52M | -14.3% |
| End cash position | $40.48M | $194.37M | $34.49M | $68.23M | -79.2% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $26.49M | $24.78M | $22.59M | $21.20M | $20.49M | +6.9% |
| Operating revenue | $26.49M | $24.78M | $22.59M | $21.20M | $20.49M | +6.9% |
| Cost of revenue | $3.37M | $3.14M | $2.65M | $2.52M | $2.48M | +7.4% |
| Gross profit | $23.12M | $21.64M | $19.94M | $18.68M | $18.01M | +6.8% |
| Research & development | $6.16M | $5.06M | $4.98M | $4.85M | $4.25M | +21.7% |
| Selling, general & admin | $37.71M | $31.18M | $29.61M | $28.78M | $27.97M | +20.9% |
| Total operating expense | $43.87M | $36.24M | $34.59M | $33.63M | $32.21M | +21.0% |
| Operating income | -$20.75M | -$14.60M | -$14.65M | -$14.95M | -$14.21M | -42.1% |
| Net interest income | -$434.00K | -$462.00K | -$480.00K | -$477.00K | -$471.00K | +6.1% |
| Pre-tax income | -$19.74M | -$13.53M | -$13.46M | -$13.64M | -$12.78M | -45.9% |
| Tax provision | $0 | $0 | $0 | $0 | $0 | — |
| Net income | -$19.74M | -$13.53M | -$13.46M | -$13.64M | -$12.78M | -45.9% |
| Net income to common | -$19.74M | -$13.53M | -$13.46M | -$13.64M | -$12.78M | -45.9% |
| Basic EPS | -0.52 | -0.36 | -0.37 | -0.38 | -0.36 | -44.4% |
| Diluted EPS | -0.52 | -0.36 | -0.37 | -0.38 | -0.36 | -44.4% |
| EBIT | -$19.30M | -$13.06M | -$12.98M | -$13.17M | -$12.31M | -47.7% |
| EBITDA | -$19.06M | -$12.77M | -$12.59M | -$12.84M | -$11.97M | -49.2% |
| Basic shares | 37.66M | 37.22M | 36.81M | 36.29M | 35.88M | +1.2% |
| Diluted shares | 37.66M | 37.22M | 36.81M | 36.29M | 35.88M | +1.2% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $45.25M | $40.48M | $23.74M | $40.14M | $153.36M | +11.8% |
| Cash & short-term investments | $141.18M | $159.26M | $168.54M | $177.43M | $182.70M | -11.4% |
| Accounts receivable | $15.71M | $15.05M | $12.23M | $12.31M | $11.30M | +4.4% |
| Inventory | $6.90M | $7.29M | $6.02M | $6.00M | $6.55M | -5.3% |
| Total current assets | $168.91M | $186.72M | $191.81M | $199.79M | $205.42M | -9.5% |
| Property, plant & equipment | $3.97M | $4.33M | $3.46M | $3.76M | $4.02M | -8.3% |
| Total assets | $178.08M | $195.80M | $199.53M | $207.69M | $213.47M | -9.1% |
| Total current liabilities | $16.18M | $19.19M | $15.17M | $15.01M | $11.83M | -15.7% |
| Long-term debt | $19.92M | $19.81M | $19.75M | $19.68M | $19.62M | +0.5% |
| Total debt | $22.12M | $22.28M | $21.34M | $21.55M | $21.76M | -0.7% |
| Total liabilities | $37.27M | $40.47M | $35.44M | $35.53M | $32.59M | -7.9% |
| Retained earnings | -$240.09M | -$220.36M | -$206.83M | -$193.36M | -$179.72M | -9.0% |
| Shareholder equity | $140.81M | $155.34M | $164.08M | $172.16M | $180.88M | -9.3% |
| Working capital | $152.73M | $167.53M | $176.64M | $184.77M | $193.59M | -8.8% |
| Net tangible assets | $140.81M | $155.34M | $164.08M | $172.16M | $180.88M | -9.3% |
| Shares issued | 37.86M | 37.49M | 37.05M | 36.60M | 35.90M | +1.0% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | -$19.74M | -$13.53M | -$13.46M | -$13.64M | -$12.78M | — | -45.9% |
| Depreciation & amortisation | $239.00K | $291.00K | $391.00K | $324.00K | $335.00K | — | -17.9% |
| Stock-based compensation | $3.72M | $3.36M | $3.35M | $3.17M | $2.35M | — | +10.8% |
| Change in working capital | -$2.98M | -$382.00K | -$580.00K | $2.99M | -$1.39M | — | -681.2% |
| Operating cash flow | -$19.30M | -$10.77M | -$11.10M | -$7.53M | -$11.40M | — | -79.1% |
| Capital expenditure | -$826.00K | -$179.00K | -$369.00K | — | -$279.00K | -$357.00K | -361.5% |
| Investing cash flow | $22.44M | $26.11M | -$6.94M | -$107.69M | -$29.61M | — | -14.0% |
| Financing cash flow | $1.63M | $1.40M | $1.64M | $2.01M | $2.00K | — | +16.3% |
| Free cash flow | -$20.12M | -$10.95M | -$11.47M | -$7.47M | -$11.68M | — | -83.7% |
| End cash position | $45.25M | $40.48M | $23.74M | $40.14M | $153.36M | — | +11.8% |
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -0.46 | -0.40 | +11.9% |
| Mar 2026 | -0.39 | -0.38 | +3.6% |
| Dec 2025 | -0.41 | -0.36 | +12.7% |
| Jun 2025 | -0.40 | -0.38 | +4.4% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | -0.46 | 4 | $27.28M | +28.7% |
| Next quarter | -0.43 | 5 | $31.72M | +28.0% |
| Current year | -1.96 | 5 | $115.48M | +29.7% |
| Next year | -1.54 | 5 | $147.07M | +27.4% |
Analyst targets & ownership
Mean target$27.29
High target$32.00
Low target$24.00
Implied upside12.75%
Analyst count7
ConsensusSTRONG BUY
Strong buy / Buy1 / 7
Hold0
Sell / Strong sell0 / 0
Held by insiders11.94%
Held by institutions87.73%
Institutions holding178
Price targets, consensus spread, insider and institutional ownership.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 18, 26 | BTIG | MAINTAINED | Buy | Buy |
| Aug 11, 26 | Canaccord Genuity | MAINTAINED | Buy | Buy |
| Aug 11, 26 | BTIG | MAINTAINED | Buy | Buy |
| May 12, 26 | Canaccord Genuity | MAINTAINED | Buy | Buy |
| Jan 28, 26 | BTIG | MAINTAINED | Buy | Buy |
| Dec 17, 25 | Canaccord Genuity | MAINTAINED | Buy | Buy |
| Dec 15, 25 | BTIG | MAINTAINED | Buy | Buy |
| Nov 5, 25 | JP Morgan | MAINTAINED | Overweight | Overweight |
| Nov 5, 25 | TD Cowen | MAINTAINED | Buy | Buy |
| Oct 21, 25 | Raymond James | INITIATED | — | Strong Buy |
| Apr 4, 25 | Ladenburg Thalmann | INITIATED | — | Buy |
| Feb 26, 25 | Canaccord Genuity | MAINTAINED | Buy | Buy |
Moving averages & technicals
SMA 10
23.21
+4.26% from price
SMA 20
20.67
+17.10% from price
SMA 50
19.52
+23.97% from price
SMA 100
19.28
+25.49% from price
SMA 200
19.16
+26.30% from price
EMA 12
22.72
+6.50% from price
EMA 26
21.10
+14.67% from price
EMA 50
20.11
+20.32% from price
RSI (14)
73.5
Overbought
MACD (12,26,9)
1.62
Hist 0.49
ATR (14)
1.05
4.35% of price
Realised vol 30D
53.6%
Annualised
Bollinger upper
26.28
20, 2σ
Bollinger lower
15.05
20, 2σ
50 / 200 cross
Golden
19.52 vs 19.16
Trend bias
Above 200
+26.30%
Risk profile
Beta vs SPY
1.31
More volatile than market
Correlation to SPY
0.32
Loosely linked
Realised vol 30D
53.6%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-30.5%
Peak to trough
Max drawdown 5Y
-63.9%
Peak to trough
ATR 14
1.05
4.35% of price
Beta (reported)
—
5Y monthly, from filing
SEC filings
Periodic Financial Reports
10-Q · 2026-08-10
Corporate Changes & Voting Matters
8-K · 2026-07-30
Corporate Changes & Voting Matters
8-K · 2026-06-02
Periodic Financial Reports
10-Q · 2026-05-11
Proxy Statements
DEFA14A · 2026-04-20
Corporate Changes & Voting Matters
8-K · 2026-02-24
Corporate Changes & Voting Matters
8-K · 2026-01-05
Corporate Changes & Voting Matters
8-K · 2026-01-02
Headlines
CeriBell Expands EEG Platform Beyond Seizures With Delirium, Pediatric Push
MarketBeat · 10d ago
CeriBell Inc (CBLL) (Q2 2026) Earnings Call Highlights: Revenue Accelerates 33% on Record ...
GuruFocus.com · 12d ago
CeriBell, Inc. Q2 2026 Earnings Call Summary
Moby · 12d ago
CeriBell (CBLL) Q2 2026 Earnings Call Transcript
Motley Fool · 12d ago
Here's What Key Metrics Tell Us About CeriBell, Inc. (CBLL) Q2 Earnings
Zacks · 12d ago
CeriBell Q2 Earnings Call Highlights
MarketBeat · 12d ago
CeriBell, Inc. (CBLL) Reports Q2 Loss, Tops Revenue Estimates
Zacks · 12d ago
Ceribell Reports Second Quarter 2026 Financial Results
GlobeNewswire · 12d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.